Received Jul 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 3 | 2142142 | PO / MO |
There was not an adverse event. Patient was administered Rotateq at 9 months, after the indicated age range for vaccine. This is for reporting purposes only.
N/A